The pathogenic role of notch activation in podocytes

Nephron - Experimental Nephrology

Volumn 111, Issue 4, 2009, Pages

  Niranjan, Thiruvur ^a   Murea, Mariana ^a   Susztak, Katalin ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Secretase inhibitors; Albuminuria; Glomerulosclerosis; Notch; Podocytes

Indexed keywords

ALBUMIN; CREATININE; DOXORUBICIN; DOXYCYCLINE; FUCOSYLTRANSFERASE; GAMMA SECRETASE INHIBITOR; JAGGED1; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; PROTEIN P53; PUROMYCIN AMINONUCLEOSIDE; STRESS ACTIVATED PROTEIN KINASE; TETRACYCLINE;

ALAGILLE SYNDROME; ALBUMINURIA; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DISEASE COURSE; ENZYME ACTIVATION; FOCAL GLOMERULOSCLEROSIS; FUCOSYLATION; GENE DELETION; GLOMERULAR DYSFUNCTION; GLOMERULOSCLEROSIS; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; GLYCOSYLATION; HUMAN; KIDNEY DEVELOPMENT; KIDNEY FAILURE; KIDNEY INJURY; LIGAND BINDING; NEPHROTIC SYNDROME; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; HUMANS; KIDNEY DISEASES; PODOCYTES; RECEPTORS, NOTCH;

EID: 67649099271     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209207     Document Type: Review

References (58)

1. Mundel P, Shankland SJ: Podocyte biology and response to injury. J Am Soc Nephrol 2002; 13: 3005-3015.
2. Mundel P, Shankland SJ: Glomerular podocytes and adhesive interaction with glomerular basement membrane. Exp Nephrol 1999; 7: 160-166.
3. Pavenstadt H, Kriz W, Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev 2003; 83: 253-307.
4. Vogelmann SU, Nelson WJ, Myers BD, Lemley KV: Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 2003; 285:F40-F48.
5. Petermann AT, Krofft R, Blonski M, Hiromura K, Vaughn M, Pichler R, Griffin S, Wada T, Pippin J, Durvasula R, et al: Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int 2003; 64: 1222-1231.
6. Petermann AT, Pippin J, Krofft R, Blonski M, Griffin S, Durvasula R, Shankland SJ: Viable podocytes detach in experimental diabetic nephropathy: potential mechanism underlying glomerulosclerosis. Nephron Exp Nephrol 2004; 98:e114-e123.
7. Bottinger EP, Bitzer M: TGF-beta signaling in renal disease. J Am Soc Nephrol 2002; 13: 2600-2610.
8. Asano T, Niimura F, Pastan I, Fogo AB, Ichikawa I, Matsusaka T: Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis. J Am Soc Nephrol 2005; 16: 2257-2262.
9. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, Bottinger EP: Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001; 108: 807-816.
10. Schiffer M, Mundel P, Shaw AS, Bottinger EP: A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis. J BiolChem 2004; 279: 37004-37012.
11. Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L, Kershaw D, Wiggins R: Podocyte depletion and glomerulosclerosis have a direct relationship in the PANtreated rat. Kidney Int 2001; 60: 957-968.
12. Cybulsky AV, McTavish AJ, Papillon J, Takano T: Role of extracellular matrix and Ras in regulation of glomerular epithelial cell proliferation. Am J Pathol 1999; 154:899-908.
13. Cybulsky AV: Extracellular matrix as a determinant of signaling responses in glomerular epithelial cells. Kidney Int 1999; 56: 1242-1246.
14. Hoppe PE, Greenspan RJ: Local function of the Notch gene for embryonic ectodermal pathway choice in Drosophila. Cell 1986; 46: 773-783.
15. Artavanis-Tsakonas S, Rand MD, Lake RJ:Notch signaling: cell fate control and signal integration in development. Science 1999; 284: 770-776.
16. Schweisguth F: Notch signaling activity. Curr Biol 2004; 14:R129-R138.
17. Callahan R, Egan SE: Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia 2004; 9: 145-163.
18. Bailey AM, Posakony JW: Suppressor of hairless directly activates transcription of enhancer of split complex genes in response to Notch receptor activity. Genes Dev 1995; 9: 2609-2622.
19. Leimeister C, Bach A, Woolf AS, Gessler M: Screen for genes regulated during early kidney morphogenesis. Dev Genet 1999; 24: 273-283.
20. Leimeister C, Externbrink A, Klamt B, Gessler M: Hey genes: a novel subfamily of hairy- and Enhancer of split related genes specifically expressed during mouse embryogenesis. Mech Dev 1999; 85: 173-177.
21. Nakagawa O, Nakagawa M, Richardson JA, Olson EN, Srivastava D: HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments. Dev Biol 1999; 216: 72-84.
22. Kao HY, Ordentlich P, Koyano-Nakagawa N, Tang Z, Downes M, Kintner CR, Evans RM, Kadesch T: A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev 1998; 12: 2269- 2277.
23. Wolfe MS: Therapeutic strategies for Alzheimer's disease. Nat Rev Drug Discov 2002; 1: 859-866.
24. Kopan R, Turner DL: The Notch pathway: democracy and aristocracy in the selection of cell fate. Curr Opin Neurobiol 1996; 6: 594-601.
25. Berset T, Hoier EF, Battu G, Canevascini S, Hajnal A: Notch inhibition of RAS signaling through MAP kinase phosphatase LIP-1 during C. elegans vulval development. Science 2001; 291: 1055-1058.
26. Newman AP, Sternberg PW: Coordinated morphogenesis of epithelia during development of the Caenorhabditis elegans uterinevulval connection. Proc Natl Acad Sci USA 1996; 93: 9329-9333.
27. Wang M, Sternberg PW: Pattern formation during C. elegans vulval induction. Curr Top Dev Biol 2001; 51: 189-220.
28. Grabher C, von Boehmer H, Look AT: Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006; 6: 347-359.
29. Ciofani M, Zuniga-Pflucker JC: Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat Immunol 2005; 6: 881-888.
30. von Boehmer H: Notch in lymphopoiesis and T cell polarization. Nat Immunol 2005; 6: 641-642.
31. Zweidler-McKay PA, He Y, Xu L, Rodriguez CG, Karnell FG, Carpenter AC, Aster JC, Allman D, Pear WS: Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B cell malignancies. Blood 2005; 106: 3898-3906.
32. Reya T, Clevers H: Wnt signalling in stem cells and cancer. Nature 2005; 434: 843-850.
33. Wilson A, Radtke F: Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett 2006; 580: 2860-2868.
34. Zecchini V, Domaschenz R, Winton D, Jones P: Notch signaling regulates the differentiation of post-mitotic intestinal epithelial cells. Genes Dev 2005; 19: 1686-1691.
35. Stanger BZ, Datar R, Murtaugh LC, Melton DA: Direct regulation of intestinal fate by Notch. Proc Natl Acad Sci USA 2005; 102: 12443-12448.
36. Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H, Aster JC, Krishna S, Metzger D, Chambon P, et al: Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 2001; 20: 3427-3436.
37. Balint K, Xiao M, Pinnix CC, Soma A, Veres I, Juhasz I, Brown EJ, Capobianco AJ, Herlyn M, Liu ZJ: Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest 2005; 115: 3166-3176.
38. Yang X, Klein R, Tian X, Cheng HT, Kopan R, Shen J: Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. Dev Biol 2004; 269: 81-94.
39. Piscione TD, Wu MY, Quaggin SE: Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. Gene Expr Patterns 2004; 4: 707- 711.
40. Sharma M, Fopma A, Brantley JG, Vanden Heuvel GB: Coexpression of Cux-1 and Notch signaling pathway components during kidney development. Dev Dyn 2004; 231: 828-838.
41. Chen L, Al-Awqati Q: Segmental expression of Notch and Hairy genes in nephrogenesis. Am J Physiol Renal Physiol 2005; 288:F939- F952.
42. Kopan R, Cheng HT, Surendran K: Molecular insights into segmentation along the proximal-distal axis of the nephron. J Am Soc Nephrol 2007; 18: 2014-2020.
43. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, Trask BJ, Kuo WL, Cochran J, et al: Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997; 16: 243- 251.
44. Kiernan AE, Cordes R, Kopan R, Gossler A, Gridley T: The Notch ligands DLL1 and JAG2 act synergistically to regulate hair cell development in the mammalian inner ear. Development 2005; 132: 4353-4362.
45. McCright B, Gao X, Shen L, Lozier J, Lan Y, Maguire M, Herzlinger D, Weinmaster G, Jiang R, Gridley T: Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 2001; 128: 491-502.
46. Cheng HT, Miner JH, Lin M, Tansey MG, Roth K, Kopan R: Gamma-secretase activity is dispensable for mesenchyme-to-epithelium transition but required for podocyte and proximal tubule formation in developingmouse kidney. Development 2003; 130: 5031-5042.
47. Cheng HT, Kim M, Valerius MT, Surendran K, Schuster-Gossler K, Gossler A, McMahon AP, Kopan R: Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 2007; 134: 801-811.
48. Wang P, Pereira FA, Beasley D, Zheng H: Presenilins are required for the formation of comma- and S-shaped bodies during nephrogenesis. Development 2003; 130: 5019-5029.
49. Susztak K, Sharma K, Schiffer M, McCue P, Ciccone E, Bottinger EP: Genomic strategies for diabetic nephropathy. J Am Soc Nephrol 2003; 14:S271-S278.
50. Susztak K, Bottinger E, Novetsky A, Liang D, Zhu Y, Ciccone E, Wu D, Dunn S, McCue P, Sharma K: Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 2004; 53: 784-794.
51. Niranjan T, Bielesz B, Gruenwald A, Ponda MP, Kopp JB, Thomas DB, Susztak K: The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008; 14: 290-298.
52. Walsh DW, Roxburgh SA, McGettigan P, Berthier CC, Higgins DG, Kretzler M, Cohen CD, Mezzano S, Brazil DP, Martin F: Coregulation of Gremlin and Notch signalling in diabetic nephropathy. Biochim Biophys Acta 2008; 1782: 10-21.
53. Shigehara T, Zaragoza C, Kitiyakara C, Takahashi H, Lu H, Moeller M, Holzman LB, Kopp JB: Inducible podocyte-specific gene expression in transgenic mice. J Am Soc Nephrol 2003; 14: 1998-2003.
54. Waters AM, Wu MY, Onay T, Scutaru J, Liu J, Lobe CG, Quaggin SE, Piscione TD: Ectopic notch activation in developing podocytescauses glomerulosclerosis. J Am Soc Nephrol 2008; 19: 1139-1157.
55. van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, Cozijnsen M, Robine S, Winton DJ, Radtke F, et al: Notch/ gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005; 435: 959-963.
56. Kopan R, Ilagan MX: Gamma-secretase: proteasome of the membrane? Nat Rev Mol Cell Biol 2004; 5: 499-504.
57. Ni CY, Murphy MP, Golde TE, Carpenter G: Gamma-secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 2001; 294: 2179-2181.
58. Tsai JY, Wolfe MS, Xia W: The search for gamma-secretase and development of inhibitors. Curr Med Chem 2002; 9: 1087-1106.